Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
Tech Nation: My Creations Have Upgrade Panels
Chapter 176

Bode-001 AIDS Miracle Drug

1,462 words 5 min read 0 views 2mo ago Source ​
Skip to the end of the chapter
Prev
Next

As for whether 'Bode-001 AIDS- specific drug' is better or worse, stronger or weaker than Xingtu Gene Company's 'EBT-002 gene therapy drug'?

First of all, the Broad Institute's 'Bode-001 AIDS- specific drug' is a qualified drug.

It is a gene-editing drug that can completely eliminate all AIDS virus in the body of AIDS patients, so it is a qualified drug.

Under such circumstances, it is natural that he will pose a huge threat to Xingtu Gene Company's 'EBT-002 gene medical agent' and seize Xingtu Gene Company's profits.

Therefore, the next competition will be about which company has more advantages and fewer disadvantages, ultimately allowing consumers to choose which company's AIDS- specific drug to use.

The biggest drawback of 'EBT-002 gene therapy agent' is its high manufacturing cost, making it difficult to significantly reduce costs.

After all, each 'RNP Complex' is produced using chemical synthesis methods, which are not only expensive in terms of equipment, but also require hundreds of procedures, making the cost very high.

The Broad Institute's 'Bode-001 AIDS drug' uses Viral Transduction Method.

The advantage of this Viral Transduction Method is that once a man-made virus is successfully created, it can reproduce and multiply on its own.

At this point, large-scale mass production is very easy, production costs are low, and R&D costs are also slightly lower than those of the 'RNP Complex' circuit, resulting in higher net profits.

The drawback of the Viral Transduction Method is that viruses are ultimately foreign substances, which will trigger a certain immune response in the human body's immune system.

Pain, numbness, itching, fever, chills, etc. are common occurrences at that time. However, there is also the possibility of an excessive immune response leading to sudden death.

In addition, there is another potential danger that threatens all of humanity: the virus can typically survive for 3 or 5 days.

Artificially created viruses, in order to function, aim to modify the body's cells, rather than being immediately killed by the human immune system upon injection.

The designers of artificial viruses must have taken advantage of the weaknesses of the human immune system and cellular defense system, and tried to reduce the response of the human immune system and cellular defense system.

Therefore, the designers of the man-made virus are like guides for bandits, allowing them to understand the situation inside the village.

This allowed the bandits to silently bypass numerous defenses and traps, eventually infiltrating the village and wreaking havoc.

If we were to compare bandits to man-made viruses, they would be artificially designed viruses that can significantly or even perfectly reduce the human immune response, allowing the artificial virus to reach cells and even the cell nucleus.

In this situation, if this specially designed artificial virus mutates out of control, it can perfectly bypass the human immune system.

Its level of terror is not much less than that of the Ebola virus, after all, this man-made virus can perfectly evade and overcome the defenses of the human immune system.

As for the probability of the mutation going out of control, no one can guarantee that.

It can only be said that the more people who are injected, the larger the base number, the greater the probability of uncontrolled mutation. In addition, it is also related to the survival time of the artificial virus.

Conversely, when the number of people receiving the injection reaches an incredibly large number, the artificial virus will inevitably mutate and become out of control.

If we hadn't done a good job in epidemic prevention and control at that time, and hadn't contained the spread of the mutated man-made virus, it would have been a disaster that affected all of humanity.

As for the level of this disaster, no one can be sure.

After all, the transmission routes of mutated man-made viruses may be limited; they cannot be transmitted through coughing, but only through limbs or blood.

Of course, besides posing a potential threat to all of humanity, this man-made virus mutation also poses other risks to individuals.

This is because viruses cannot guarantee 100% stability and accuracy when replicating themselves.

The Cas9 protein, which is produced by artificial viruses, may also attack gene segments of normal cells.

This behavior naturally poses certain risks to the human body. Therefore, while the Viral Transduction Method has many cost advantages, it is also quite dangerous.

In contrast, the disadvantages of the 'Bode-001 AIDS- specific drug' using the Viral Transduction Method are the advantages of Xingtu Gene Company's 'EBT-002 gene therapy drug'.

The advantage of 'EBT-002 gene therapy agent' is its high safety; the RNP Complex is not a virus at all.

There is naturally no possibility of viral mutation, and because the injection slightly repairs the genetic defects of the recipient, one treatment can prevent reinfection with AIDS.

It can be said that apart from its relatively high cost, the 'EBT-002 gene therapy agent' has no major drawbacks and is full of advantages.

Of course, the high cost is not a big deal, because anyone with a brain knows that the Broad Institute's 'Bode-001 AIDS drug' is definitely not cheap.

After all, dozens of Wall Street investment firms and major global pharmaceutical giants have invested a total of $35 billion in the Broad Institute alone.

Their goal was to obtain the current achievement, the 'Bode-001 AIDS treatment drug'. Under such circumstances, they naturally wouldn't sell the 'Bode-001 AIDS treatment drug' at a bargain price.

Therefore, their advantage of low cost cannot be realized, and naturally they cannot bring a fatal impact to Xingtu Technology.

While there was no fatal impact, there was certainly a massive impact.

After all, their production costs are low. Even if the price of the AIDS drug drops by a few hundred yuan, their profit margin is the same as that of Xingtu Gene Company, with a large range of fluctuations in price reduction.

Furthermore, they hold the power of discourse in overseas television stations, newspapers, and even local internet media.

Therefore, they can exaggerate the benefits of 'Bode-001, a cure for AIDS' while ignoring the drawbacks.

They might even go so far as to denigrate or slander Xingtu Technology's 'EBT-002 gene therapy drug' as unsafe, claiming that someone who was injected with the drug died, and so on.

With such overwhelming public opinion, even falsehoods can be presented as truth; this is the benefit of controlling the narrative.

In addition, they can also suppress Xingtu Gene Company by using public opinion or other forms of pressure to prevent Xingtu Gene's drugs from being listed overseas.

At this time, with the West developing an effective AIDS drug that can replace Xingtu Gene Company will definitely face a huge impact.

Of course, these methods have not yet been demonstrated; Lin Feng is merely inferring the possibilities based on the news he has seen.

After all, with the Broad Institute announcing the successful development of AIDS drug 'Bode-001', countless media outlets around the world praised them to the skies.

They exclaimed that the Broad Institute was amazing, the world's strongest gene research company, and how incredible the 'Bode-001 AIDS drug' was.

In this regard, none of the drawbacks and disadvantages of 'Bode-001 AIDS treatment' are mentioned.

Of course, along with the news of Bode Institute's great success, Medical Bureau in various countries around the world also announced that they would officially accelerate the review of 'Bode-001 AIDS treatment drug' so that everyone could be treated for AIDS as soon as possible.

Among these, Xingtu Technology's 'EBT-002 gene therapy drug' seems to have been forgotten, with no mention of expediting the approval process.

It's been over two months since the 'EBT-002 gene therapy drug' was submitted for clinical trials, and apart from Great Xia and a few other small, relatively unknown countries that expedited the approval process, the results have been mixed.

Those well-known large countries, such as the transgender country, the Southern Yue Kingdom, and India, have not approved the clinical trial application for 'EBT-002 gene therapy drug', and its market launch is nowhere in sight.

Meanwhile, the 'Bode-001 AIDS drug' developed by the Broad Institute of the American Empire could be approved more quickly.

Judging from their appearance, they may only need one or two months to officially launch. This kind of differential treatment is truly regrettable.

"At this rate, I'm afraid all AIDS patients in the world will be cured, and our 'EBT-002 gene therapy drug' won't be able to be marketed overseas."

Is this the power of capital? It's certainly a headache.

This underhanded tactic of "I may have beaten you, but I can prevent you from going public" is indeed very effective.

As Lin Feng considered the future, he felt a headache coming on.

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Lin Feng
Xingtu Technology
Great Xia
American Empire

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS